End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.17 MYR | +0.96% | +3.59% | +5.32% |
Apr. 12 | Penumbra, Inc. : The underdog in healthcare | |
Feb. 26 | Inari Amertron Berhad Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- With an expected P/E ratio at 33.87 and 27.38 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
- Revenue estimates are regularly revised downwards for the current and coming years.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Semiconductors
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+5.32% | 2.54B | B+ | ||
+86.74% | 2,275B | B- | ||
+40.81% | 673B | A- | ||
+25.00% | 647B | C | ||
+11.57% | 266B | B- | ||
+34.04% | 216B | B- | ||
+14.41% | 178B | A- | ||
+46.81% | 139B | B+ | ||
-36.62% | 135B | C+ | ||
+46.85% | 115B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- INARI Stock
- Ratings Inari Amertron